DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Agonist

Agonist

  • Label (PDF)

    Label (PDF)

  • Pharmacokinetics and Pharmacology of Drugs Used in Children

    Pharmacokinetics and Pharmacology of Drugs Used in Children

  • International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology

    International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology

  • Effects of the Kappa-Opioid Receptor Agonist, U69593, on the Development of Sensitization and on the Maintenance of Cocaine Self

    Effects of the Kappa-Opioid Receptor Agonist, U69593, on the Development of Sensitization and on the Maintenance of Cocaine Self

  • QUESTION 1 (Principle: the Graded Dose-Response Curve)

    QUESTION 1 (Principle: the Graded Dose-Response Curve)

  • Introduction to Pharmacodynamics Reza Karimi 6

    Introduction to Pharmacodynamics Reza Karimi 6

  • The Pharmacology of an Agonist Medication to Treat Stimulant Use Disorder

    The Pharmacology of an Agonist Medication to Treat Stimulant Use Disorder

  • Inside-Out Neuropharmacology of Nicotinic Drugs

    Inside-Out Neuropharmacology of Nicotinic Drugs

  • Are All GLP-1 Agonists Equal in the Treatment of Type 2 Diabetes?

    Are All GLP-1 Agonists Equal in the Treatment of Type 2 Diabetes?

  • Update on the Role of Alpha-Agonists in Glaucoma Management

    Update on the Role of Alpha-Agonists in Glaucoma Management

  • Essential Psychopharmacology

    Essential Psychopharmacology

  • Glucagon GLP-1 Receptor Ligand Binding Assay Figure 9 – Compound Library % Inhibition Distribution

    Glucagon GLP-1 Receptor Ligand Binding Assay Figure 9 – Compound Library % Inhibition Distribution

  • Prediction of Median Lethal Dose by QSAR Method with Their Applications

    Prediction of Median Lethal Dose by QSAR Method with Their Applications

  • Pharmacology Part 1: Introduction to Pharmaoclogy and Pharmacodynamics

    Pharmacology Part 1: Introduction to Pharmaoclogy and Pharmacodynamics

  • PHARMACODYNAMICS Receptor Pharmacology

    PHARMACODYNAMICS Receptor Pharmacology

  • Agonist-Antagonist Opioids: Theory and Clinical Practice Carl Rosow MD

    Agonist-Antagonist Opioids: Theory and Clinical Practice Carl Rosow MD

  • Adrenoceptor Pharmacology

    Adrenoceptor Pharmacology

  • WHO Expert Committee on Drug Dependence Pre-Review ……………

    WHO Expert Committee on Drug Dependence Pre-Review ……………

Top View
  • A Selective Metabotropic Glutamate Receptor 7 Agonist: Activation of Receptor Signaling Via an Allosteric Site Modulates Stress Parameters in Vivo
  • Dopamine Partial Agonist Reverses Amphetamine Withdrawal in Rats Cristina Orsini, Ph.D., George F
  • Key Concepts in Psychopharmacology
  • The Hitchhiker's Guide to Clinical Pharmacology
  • Pharmacodynamics: the Study of Drug Action
  • Pharmacology of Opioids
  • PHARMACODYNAMICS (PD) a Drug Effect on the Body Over a Time-Course
  • Introduction to Pharmacodynamics 1 University of Hawai‘I Hilo Pre-Nursing Program NURS 203 – General Pharmacology Danita Narciso Pharm D
  • Agonists and Antagonists
  • (+)-PHNO to Dopamine D2/D3 Receptors in Rat Brain: Lack of Correspondence to the D2 Receptor Two-Affinity-State Model
  • Receptor and Binding Studies Peter Hein, Martin C
  • A Toxicity Prediction Tool for Potential Agonist/Antagonist Activities in Molecular Initiating Events Based on Chemical Structures
  • 1 Picomolar Affinity Antagonist and Sustained Signaling Agonist Peptide Ligands for the Adrenomedullin and Calcitonin Gene-Rela
  • The Evolving Psychopharmacology of Major Depressive Disorder
  • Opioid Agonist Therapy
  • A Nonpeptide Oxytocin Receptor Agonist for a Durable Relief of Inflammatory Pain
  • E-Issn No : 2455-295X | Volume : 2 | Issue : 11 | Nov 2016
  • Toxicity of an Fc-Engineered Anti-CD40 Antibody Is Abrogated by Intratumoral Injection and Results in Durable Antitumor Immunity


© 2024 Docslib.org    Feedback